Evaxion A (EVAX) EBT (2020 - 2026)

Evaxion A (EVAX) posted EBT of -$3.8 million for Q1 2026, up 37.72% on a QoQ basis from -$6.2 million in Q4 2025, and down 116.99% year-over-year from $22.6 million in Q1 2025.

Evaxion A (EVAX) EBT (2020 - 2026) Analysis & Trends

Evaxion A's EBT history runs 7 years deep, the most recent figure standing at -$3.8 million for Q1 2026.

  • Quarterly EBT fell 116.99% year-over-year to -$3.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$10.7 million (up 24.18% YoY) and the FY2025 annual result came in at -$8.6 million, up 24.13% from the prior year.
  • EBT was -$3.8 million for Q1 2026 at Evaxion A, up from -$6.2 million in the prior quarter.
  • Across five years, EBT topped out at $4.4 million in Q3 2025 and bottomed at -$7.0 million in Q4 2022.
  • A 5-year average of -$3.6 million and a median of -$4.7 million in 2023 frame the typical range for EBT.
  • Annual changes were most pronounced in 2024 — EBT plunged 639600.0% — and 2025, when it surged 314.28%.
  • Evaxion A's EBT stood at -$7.0 million in 2022, then soared by 33.29% to -$4.7 million in 2023, then grew by 16.94% to -$3.9 million in 2024, then slumped by 58.15% to -$6.2 million in 2025, then surged by 37.72% to -$3.8 million in 2026.
  • Business Quant data shows EVAX's EBT at -$3.8 million in Q1 2026, -$6.2 million in Q4 2025, and $4.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -36.97 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -15.31 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 259.22 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 1.25 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 831.20 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -26.94 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 438.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - -453.82 Mn
10 Evaxion A 1.23 Bn 1.23 Bn - -3.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3.85 Mn
Dec 31, 2025 -6.17 Mn
Sep 30, 2025 4.35 Mn
Jun 30, 2025 -5.03 Mn
Mar 31, 2025 -1.77 Mn
Dec 31, 2024 -3.90 Mn
Sep 30, 2024 -2.03 Mn
Jun 30, 2024 -6.40 Mn
Mar 31, 2024 976,000.00
Dec 31, 2023 -4.70 Mn
Sep 30, 2023 -5.87 Mn
Jun 30, 2023 -1,000.00
Mar 31, 2023 -6.44 Mn
Dec 31, 2022 -7.05 Mn
Sep 30, 2022 -5.92 Mn
Jun 30, 2022 -1.60 Mn
Mar 31, 2022 -6.04 Mn
Dec 31, 2021 -7.05 Mn
Sep 30, 2021 -17.66 Mn
Jun 30, 2021 423,000.00